These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31322413)

  • 1. Pharmacotherapeutic options for atypical meningiomas.
    Ahsan SA; Chendeb K; Profyris C; Teo C; Sughrue ME
    Expert Opin Pharmacother; 2019 Oct; 20(15):1831-1836. PubMed ID: 31322413
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the systemic therapy for recurrent meningiomas and the challenges ahead.
    Li Y; Drappatz J
    Expert Rev Neurother; 2023; 23(11):995-1004. PubMed ID: 37695700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The controversial role of Bevacizumab in the treatment of patients with intracranial meningioma: a comprehensive literature review.
    Scerrati A; Mongardi L; Visani J; Lofrese G; Cavallo MA; Fiorentino A; De Bonis P
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):197-203. PubMed ID: 32116057
    [No Abstract]   [Full Text] [Related]  

  • 6. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
    Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early adjuvant radiotherapy in the treatment of atypical meningioma.
    Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
    J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in chemotherapy for meningiomas: a review.
    Moazzam AA; Wagle N; Zada G
    Neurosurg Focus; 2013 Dec; 35(6):E18. PubMed ID: 24289126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of unresectable skull base meningiomas with somatostatin analogs.
    Schulz C; Mathieu R; Kunz U; Mauer UM
    Neurosurg Focus; 2011 May; 30(5):E11. PubMed ID: 21529167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection.
    Hardesty DA; Wolf AB; Brachman DG; McBride HL; Youssef E; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2013 Aug; 119(2):475-81. PubMed ID: 23394332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Atypical and Anaplastic Meningiomas.
    Buttrick S; Shah AH; Komotar RJ; Ivan ME
    Neurosurg Clin N Am; 2016 Apr; 27(2):239-47. PubMed ID: 27012388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Meningiomas: Recurrence, Reoperation, and Radiotherapy.
    Klinger DR; Flores BC; Lewis JJ; Hatanpaa K; Choe K; Mickey B; Barnett S
    World Neurosurg; 2015 Sep; 84(3):839-45. PubMed ID: 25916182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer.
    Wilson TJ; Heth JA
    J Clin Neurosci; 2012 Mar; 19(3):468-9. PubMed ID: 22245272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic Atypical and Anaplastic Meningioma: A Case Series and Review of the Literature.
    Kessler RA; Garzon-Muvdi T; Yang W; Weingart J; Olivi A; Huang J; Brem H; Lim M
    World Neurosurg; 2017 May; 101():47-56. PubMed ID: 28143726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?
    Marcus HJ; Price SJ; Wilby M; Santarius T; Kirollos RW
    Br J Neurosurg; 2008 Aug; 22(4):520-8. PubMed ID: 18803079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of radiosurgery during management of aggressive meningiomas.
    Harris AE; Lee JY; Omalu B; Flickinger JC; Kondziolka D; Lunsford LD
    Surg Neurol; 2003 Oct; 60(4):298-305; discussion 305. PubMed ID: 14505844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radiotherapy following gross-total resection of atypical meningiomas.
    Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
    J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.